Literature DB >> 10762539

Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channels.

J E Mickle1, M I Milewski, M Macek, G R Cutting.   

Abstract

The protein defective in cystic fibrosis (CF), the CF transmembrane-conductance regulator (CFTR), functions as an epithelial chloride channel and as a regulator of separate ion channels. Although the consequences that disease-causing mutations have on the chloride-channel function have been studied extensively, little is known about the effects that mutations have on the regulatory function. To address this issue, we transiently expressed CFTR-bearing mutations associated with CF or its milder phenotype, congenital bilateral absence of the vas deferens, and determined whether mutant CFTR could regulate outwardly rectifying chloride channels (ORCCs). CFTR bearing a CF-associated mutation in the first nucleotide-binding domain (NBD1), DeltaF508, functioned as a chloride channel but did not regulate ORCCs. However, CFTR bearing disease-associated mutations in other domains retained both functions, regardless of the associated phenotype. Thus, a relationship between loss of CFTR regulatory function and disease severity is evident for NBD1, a region of CFTR that appears important for regulation of separate channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762539      PMCID: PMC1378012          DOI: 10.1086/302893

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  70 in total

1.  Identification of six novel mutations in the CFTR gene of patients from Bulgaria by screening the twenty seven exons and exon/intron boundaries using DGGE and direct DNA sequencing.

Authors:  A Savov; B Mercier; L Kalaydjieva; C Férec
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

2.  Asymptomatic carrier of two CFTR mutations: consequences for prenatal diagnosis?

Authors:  C Verlingue; A David; M P Audrezet; M G Le Roux; B Mercier; J P Moisan; C Ferec
Journal:  Prenat Diagn       Date:  1993-12       Impact factor: 3.050

3.  Wild type but not deltaF508 CFTR inhibits Na+ conductance when coexpressed in Xenopus oocytes.

Authors:  M Mall; A Hipper; R Greger; K Kunzelmann
Journal:  FEBS Lett       Date:  1996-02-26       Impact factor: 4.124

4.  Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses.

Authors:  C Férec; C Verlingue; P Parent; J F Morin; J P Codet; G Rault; M Dagorne; A Lemoigne; H Journel; M Roussey
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

5.  Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents.

Authors:  E M Schwiebert; T Flotte; G R Cutting; W B Guggino
Journal:  Am J Physiol       Date:  1994-05

6.  Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice.

Authors:  B R Grubb; R N Vick; R C Boucher
Journal:  Am J Physiol       Date:  1994-05

7.  Interaction between cystic fibrosis transmembrane conductance regulator and outwardly rectified chloride channels.

Authors:  B Jovov; I I Ismailov; B K Berdiev; C M Fuller; E J Sorscher; J R Dedman; M A Kaetzel; D J Benos
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

8.  Regulation of epithelial sodium channels by the cystic fibrosis transmembrane conductance regulator.

Authors:  I I Ismailov; M S Awayda; B Jovov; B K Berdiev; C M Fuller; J R Dedman; M Kaetzel; D J Benos
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

9.  Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients.

Authors:  B Mercier; C Verlingue; W Lissens; S J Silber; G Novelli; M Bonduelle; M P Audrézet; C Férec
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

10.  A cluster of cystic fibrosis mutations in exon 17b of the CFTR gene: a site for rare mutations.

Authors:  B Mercier; W Lissens; G Novelli; L Kalaydjieva; M de Arce; N Kapranov; N Canki Klain; X Estivill; A Palacio; S Cashman
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

View more
  5 in total

1.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

2.  A sequence upstream of canonical PDZ-binding motif within CFTR COOH-terminus enhances NHERF1 interaction.

Authors:  Neeraj Sharma; Jessica LaRusch; Patrick R Sosnay; Laura B Gottschalk; Andrea P Lopez; Matthew J Pellicore; Taylor Evans; Emily Davis; Melis Atalar; Chan-Hyun Na; Gedge D Rosson; Deborah Belchis; Michal Milewski; Akhilesh Pandey; Garry R Cutting
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-28       Impact factor: 5.464

Review 3.  Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.

Authors:  D A S de Souza; F R Faucz; L Pereira-Ferrari; V S Sotomaior; S Raskin
Journal:  Andrology       Date:  2017-12-07       Impact factor: 3.842

4.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

5.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Authors:  Alice E Davidson; Ian D Millar; Jill E Urquhart; Rosemary Burgess-Mullan; Yusrah Shweikh; Neil Parry; James O'Sullivan; Geoffrey J Maher; Martin McKibbin; Susan M Downes; Andrew J Lotery; Samuel G Jacobson; Peter D Brown; Graeme C M Black; Forbes D C Manson
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.